ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 1000

$914K Total Retail Price of All Prescriptions

Rank: 69 out of 1000

590 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 590 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 590 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 11,172 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,025 565 S3 1 1
METFORMIN HCL 587 355 2 8
FUROSEMIDE 558 396 3 7
POTASSIUM CHLORIDE 443 342 4 10
LISINOPRIL 422 287 5 5
TRAMADOL HCL 403 244 6 13
OMEPRAZOLE 378 200 7 2
CRESTOR 338 250 8 30
CEPHALEXIN 270 179 9 90
SIMVASTATIN 264 204 10 3
ATENOLOL 251 193 11 24
LEVOTHYROXINE SODIUM 248 188 12 4
ZOLPIDEM TARTRATE 247 117 13 16
AMLODIPINE BESYLATE 230 173 14 6
NEXIUM 202 113 15 23
LYRICA 186 92 16 47
WARFARIN SODIUM 185 156 17 22
PRAVASTATIN SODIUM 184 139 18 12
ATORVASTATIN CALCIUM 181 139 19 18
CIPROFLOXACIN HCL 168 124 20 46
METOPROLOL TARTRATE 162 125 21 19
CARVEDILOL 157 108 22 15
LOVAZA 155 93 23 148
HYDROCHLOROTHIAZIDE 154 137 24 9
GABAPENTIN 146 110 25 11
ESCITALOPRAM OXALATE 144 67 26 60
RANITIDINE HCL 144 118 26 37
PANTOPRAZOLE SODIUM 143 120 28 28
CITALOPRAM HBR 143 79 28 17
CLOPIDOGREL 138 117 30 35
DONEPEZIL HCL 123 115 31 32
TAMSULOSIN HCL 121 113 32 33
CELEBREX 116 77 33 98
RAMIPRIL 115 98 34 77
SYNTHROID 114 89 35 91
GLIMEPIRIDE 110 81 36 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 50 37 20
ISOSORBIDE MONONITRATE ER 103 85 38 71
VERAPAMIL ER 101 36 39 86
MELOXICAM 101 81 39 14
PLAVIX 100 90 41 49
TRIAMTERENE-HCTZ 100 65 41 48
BENAZEPRIL HCL 100 66 41 61
SPIRIVA 96 57 44 64
DICLOFENAC SODIUM 93 56 45 123
MECLIZINE HCL 92 85 46 80
METOPROLOL SUCCINATE 85 57 47 21
FLUCONAZOLE 84 36 48 102
ALLOPURINOL 83 53 49 31
PROMETHAZINE HCL 82 56 R 50 54
DOXYCYCLINE HYCLATE 82 63 50 97
NAPROXEN 75 46 52 81
SINGULAIR 75 45 52 84
DIGOXIN 74 50 54 52
PHENYTOIN SODIUM EXTENDED 73 18 55 115
AMITRIPTYLINE HCL 71 62 R 56 45
AZITHROMYCIN 71 43 56 36
TIZANIDINE HCL 69 16 58 76
ENALAPRIL MALEATE 69 35 58 58
CYMBALTA 68 31 60 53
AZOR 67 53 61 334
LOSARTAN POTASSIUM 67 42 61 25
INSULIN SYRINGE 65 38 63 93
VYTORIN 65 60 63 201
BENICAR 63 46 65 263
DOXEPIN HCL 62 62 66 176
JANUMET 61 50 67 195
LIPITOR 60 37 68 170
FAMOTIDINE 58 47 69 88
SPIRONOLACTONE 58 49 69 78
KLOR-CON M10 58 39 69 216
ESTRADIOL 57 27 R 72 114
CEFDINIR 57 37 72 122
PROPRANOLOL HCL 55 55 74 135
NOVOLOG MIX 70-30 FLEXPEN 54 14 75 269
GLIPIZIDE 54 44 75 62
LEVEMIR FLEXPEN 54 21 75 205
KLOR-CON 10 54 44 75 104
MEGESTROL ACETATE 54 53 R 75 134
PROAIR HFA 53 25 80 50
FLUOXETINE HCL 53 37 80 51
GLYBURIDE 53 53 R 80 92
METFORMIN HCL ER 52 40 83 44
GLYBURIDE-METFORMIN HCL 52 42 R 83 121
CLONIDINE HCL 51 45 85 27
POLYETHYLENE GLYCOL 3350 51 27 85 69
VICTOZA 3-PAK 50 0 87 446
TRAZODONE HCL 50 39 87 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.